The stock price will rise when revenues rise. In my opinion, the upcoming 10Q (which will arrive most likely in about 2 weeks), will contain Chartis and Celgene revenues. People are underestimating the Celgene revenues. MMR Pro gets launched in May. I believe the 10Q is our turning point.